Overexpression of Epidermal Growth Factor Receptor as a Prognostic Factor in Colorectal Cancer on the Basis of the Allred Scoring System

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s42446
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Role of Epidermal Growth Factor Receptor in Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

C-Met Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?

Journal of Oncology
Oncology
2009English

Estrogen Receptor Β and Epidermal Growth Factor Receptor as Early-Stage Prognostic Biomarkers of Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2010English

Epidermal Growth Factor as a Prognostic Biomarker in Chronic Kidney Diseases

Annals of Translational Medicine
Medicine
2016English

Transactivation of Epidermal Growth Factor Receptor Through Platelet-Activating Factor/Receptor in Ovarian Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

The Expression of Multiple Proteins as Prognostic Factors in Colorectal Cancer: Cathepsin D, P53, COX-2, Epidermal Growth Factor Receptor, C-erbB-2, and Ki-67

Gut and Liver
HepatologyGastroenterology
2014English

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

Clinical Cancer Research
Cancer ResearchOncology
2010English

Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer

Cancer Control
MedicineOncologyHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy